Clinical Trial Update: Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 [Phase 3]

View source ↗

Summary

Phase 3 immunogenicity and safety study of GlaxoSmithKline's combined measles-mumps-rubella-varicella vaccine has completed, with results posted in 2017. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• Priorix-Tetra (Measles, Mumps, Rubella, Varicella vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Measles, Varicella | Phase 3 | Status: COMPLETED | Results posted: 2017-04-24